Stat News • 2/18/2026

Korsana Biosciences has raised $175 million to advance its Alzheimer’s antibody therapy. Investors believe there is potential for more Alzheimer’s antibody therapies in the market.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.












